FibrAlign
ApprovedFibralign is an award-winning, Stanford-spinout company that produces novel therapeutic biomedical devices that are designed to address major unmet medical needs.
Founded
2015
Focus
Regenerative MedicineMedical Devices
About
Fibralign is an award-winning, Stanford-spinout company that produces novel therapeutic biomedical devices that are designed to address major unmet medical needs.
Funding History
6Total raised: $3.0M
Grant$682KNCIAug 16, 2021
Grant$33KNCIAug 31, 2020
Grant$253KNCISep 12, 2019
Grant$2KNCIAug 6, 2019
Company Info
TypePrivate
Founded2015
LocationMenlo Park, United States
StageApproved
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile